rosiglitazone has been researched along with Hepatoblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carbonara, G; Fracchiolla, G; Laghezza, A; Lavecchia, A; Loiodice, F; Novellino, E; Piemontese, L; Tortorella, P; Trisolini, R | 1 |
1 other study(ies) available for rosiglitazone and Hepatoblastoma
Article | Year |
---|---|
Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARalpha and PPARgamma agonist activity.
Topics: Binding Sites; Cell Line, Tumor; Computer Simulation; Hepatoblastoma; Humans; Liver Neoplasms; Models, Molecular; Molecular Structure; PPAR alpha; PPAR gamma; Propionates; Structure-Activity Relationship; Thermodynamics | 2008 |